Skip to content

Clinical trials

Adenocarcinoma trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Hong Kong Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20093
20101
20142
20161
20172
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott1
Ariad Pharmaceuticals1
AstraZeneca1
Boehringer Ingelheim1
Celgene1
Chinese University of Hong Kong1
Daiichi Sankyo1
Daiichi Sankyo Co., Ltd.1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma16
Carcinoma7
Carcinoma, Non-Small-Cell Lung6
Neoplasms6
Digestive System Neoplasms5
Neoplasms by Site5
Digestive System Diseases4
Neoplasms by Histologic Type4
Colonic Neoplasms3
Endocrine Gland Neoplasms3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.